News

RNA Molecular Signal of Severe Fetal Growth Restriction Found by Mirvie

January 30, 2025

According to new data, Mirvie’s RNA platform can predict which unborn babies have severe growth restriction—a leading cause of stillbirth—far more accurately than current methods.

Mirvie's technology can now predict severe growth restriction in pregnancy - a leading cause of stillbirth

January 30, 2025

Mirvie RNA platform first to uncover a unique molecular signal for babies at risk

Interview: On the hunt for the earliest signs of high-risk pregnancies

January 30, 2025

Californian biotech firm Mirvie is pioneering a new approach to high risk pregnancies, by tracking a unique molecular signal associated with a leading cause of stillbirth.

Q&A: RNA platform predicts severe fetal growth restriction months before birth

January 30, 2025

Using Mirvie’s unique RNA platform is starting to expedite the amount of conditions we can identify very early in the pregnancy to help identify those at most risk

Venture capital firms making bets on maternal health

August 19, 2024

"Saving the lives of mothers and babies is in everyone's interest, so for breakthrough innovations like Mirvie and Vitara, there is a lot of space to obtain reimbursement," said Alex Morgan, a partner at Khosla Ventures.

The silent epidemic within the maternal health crisis

September 25, 2024

Screening tests like (Mirvie's) offer tremendous value to everyone involved, from the doctor and care team to the mom and her unborn child. Identifying those most at risk for complications will allow for early intervention, when every action possible can be taken to create a healthy pregnancy.

Why biology is catalyzing breakthroughs in women’s health

December 10, 2024

The new wave of startups in this area are focused on advancing the field to better serve women.

Birthing mothers’ near-death experience rates are 100 times higher than maternal mortality—and we don’t even know exactly why

May 10, 2024

We need more support to create a world where every pregnancy is as healthy and as safe as possible.

Blood test maker Mirvie ushers in Preeclampsia Awareness Month with prevention toolkit

July 3, 2024

The “Preeclampsia Prevention is Possible” campaign website includes a collection of downloadable resources aimed mainly at helping clinicians better recognize the early signs of the condition and shape their care plans for high-risk patients.

Patients interested in learning about preeclampsia risk

March 27, 2024

The majority of childbearing-age people would value predictive testing for preeclampsia and report they would act on this information, according to a study in BMC Pregnancy and Childbirth.

Read up on our latest news

Featured Story

Media Coverage